source
- Sanofi R&D chief urges Western pharma to factor China’s growing innovation into pipelinesSanofi’s newly appointed head of research and development said on Wednesday that Western pharmaceutical companies can no longer overlook China’s rapid progress in biopharma innovation. He noted th…
- Arrowhead’s experimental RNAi drug ARO-MAPT cuts tau protein by 73% in early human trialArrowhead Pharmaceuticals said its experimental RNA interference therapy, ARO-MAPT, lowered the Alzheimer’s‑linked tau protein in a first‑in‑human study of healthy volunteers. The early‑stage tria…